SCHEMBL734337

SCHEMBL734337

CCCCC1(N(C)C)CC=C(c2[nH]c3ccc(OC)cc3c2C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
HTR6 P50406 7/20 0.40
KDM4E B2RXH2 5/20 0.40
HTR7 P34969 5/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
CYP1A2 P05177 2/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
MAPT P10636 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734846 0.89 KDM4E (0.33) ALOX5HTR6KDM4EHTR7KMT2A
SCHEMBL735401 0.86 OPRM1 (0.39) HTR6KDM4EHTR7KMT2AMEN1
SCHEMBL734534 0.84 OPRM1 (0.39) HTR6KDM4EHTR7KMT2AMEN1
SCHEMBL735115 0.83 MEN1 (0.37) KMT2AMEN1SLC6A2CYP2C9SLC6A4
SCHEMBL736437 0.83 KMT2A (0.46) ALOX5HTR6KDM4EHTR7KMT2A
SCHEMBL733907 0.83 MEN1 (0.38) KMT2AMEN1HTR2AHTR2C
SCHEMBL734296 0.76 OPRM1 (0.50) ALOX5HTR6KDM4EHTR7KMT2A
SCHEMBL733728 0.75 HTR2A (0.39) HTR6KDM4EKMT2AMEN1HTR2A
SCHEMBL733588 0.75 MAPKAPK2 (0.41) HTR6KDM4EHTR7KMT2AMEN1
SCHEMBL733994 0.74 KDM4E (0.45) HTR6KDM4EKMT2AMEN1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 ALOX5 274/4885HTR6 254/4885KDM4E 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.